Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The efficacy of short-term interferon-beta therapy for type C cirrhotic patients with genotype 2a and low virus load.

Internal medicine (Tokyo, Japan) - 1 Jan 2008

Arase Yasuji, Suzuki Fumitaka, Sezaki Hitomi, Kawamura Yusuke, Suzuki Yoshiyuki, Kobayashi Masahiro, Akuta Norio, Hosaka Tetsuya, Yatsuji Hiromi, Kobayashi Mariko, Saitoh Satoshi, Ikeda Kenji, Kumada Hiromitsu

Abstract excerpt

OBJECTIVE: The aim of this study was to elucidate the efficacy of short-term interferon (IFN) therapy for type C cirrhotic patients with genotype 2a and low virus load. METHODS: The present study was retrospective cohort study. Inclusion criteria were liver cirrhosis, hepatitis C virus (HCV) genotype 2a, the serum HCV RNA level of less than 100 KIU/mL, and IFN period of 6 or 8 weeks. Twenty-five consecutive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Administration Schedule

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Interferon-beta

Share to Liver Cirrhosis

Share to Treatment Outcome

Share to Viral Load

Source

Identifiers

PMID: 18552464
DOI: 10.2169/internalmedicine.47.0886

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The efficacy of short-term interferon-beta therapy for type C cirrhotic patients with genotype 2a and low virus load.PMID 18552464Read ↗

The efficacy of short-term interferon-beta therapy for chronic hepatitis C patients with low virus load.Semantic proximity Read ↗

The efficacy of 24-week interferon monotherapy for type C liver cirrhosis in Japanese patients with genotype 1b and low virus load.Semantic proximity Read ↗

Efficacy of short-term interferon therapy for patients infected with hepatitis C virus genotype 2a.Semantic proximity Read ↗

Efficacy of interferon monotherapy to 394 consecutive naive cases infected with hepatitis C virus genotype 2a in Japan: therapy efficacy as consequence of tripartite interaction of viral, host and interferon treatment-related factors.Semantic proximity Read ↗

Prolonged negative HCV-RNA status led to a good outcome in chronic hepatitis C patients with genotype 1b and super-high viral load.Semantic proximity Read ↗

Four-week pegylated interferon alpha-2a monotherapy for chronic hepatitis C with genotype 2 and low viral load: a pilot, randomized study.Semantic proximity Read ↗

Effective interferon therapy for chronic hepatitis C patients with low viral loads.Semantic proximity Read ↗

The efficacy of interferon-beta monotherapy for elderly patients with type C hepatitis of genotype 2.Semantic proximity Read ↗

Short- and long-term outcome of interferon therapy for chronic hepatitis B infection.Semantic proximity Read ↗

Virological responses in chronic hepatitis C patients undergoing prolonged therapy with low-dose Peg-IFNα-2a.Semantic proximity Read ↗

Pretreatment viral load and response to prolonged interferon-alpha course for chronic hepatitis C.Semantic proximity Read ↗

Association of serum interleukin-8 with virologic response to antiviral therapy in patients with chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.